CBWD5 Activators
Forskolin and IBMX elevate cAMP levels, a crucial secondary messenger, indirectly fostering an environment where protein kinase A is more active, leading to phosphorylation changes that can engage CBWD5. Similarly, PMA's activation of protein kinase C, and Ionomycin's facilitation of calcium influx, open channels for calcium-dependent kinases to modify proteins, possibly including CBWD5. Genistein's inhibition of tyrosine kinases alters cell signaling networks, offering alternative routes for CBWD5 activation.
The impact of LY294002 and PD98059 extends beyond their inhibition of PI3K and MEK, respectively. These actions disrupt established pathways, potentially triggering a cascade of compensatory mechanisms within the cell, which may pivot to activate CBWD5. In the realm of epigenetics, Trichostatin A and 5-Azacytidine reshape the landscape of gene expression, allowing for potential upregulation of CBWD5. Metabolic pathways also hold sway over CBWD5's fate, with AICAR's activation of AMPK signaling a recalibration of energy balance within the cell that can touch upon CBWD5. Anisomycin's prompt to stress kinase pathways and Okadaic Acid's inhibition of phosphatases tilt the phosphorylation equilibrium, creating a context where CBWD5 activity can be influenced.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, elevating cAMP by preventing its degradation, which can enhance PKA activity and subsequent phosphorylation of CBWD5. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can phosphorylate a wide range of substrates including CBWD5, assuming it is within the scope of PKC’s target proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate CaMK and other calcium-dependent proteins that may affect CBWD5 activity through phosphorylation events. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases, altering phosphorylation patterns within cells, which can lead to activation of signal transduction pathways involving CBWD5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, leading to alterations in downstream signaling cascades that can result in compensatory activation of proteins, potentially including CBWD5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, impacting the MAPK/ERK pathway, which can lead to changes in protein phosphorylation including the activation of CBWD5. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to chromatin remodeling that can affect gene expression profiles, including the upregulation of CBWD5. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, leading to demethylation and potentially increased expression of genes, including CBWD5. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can modulate energy balance and metabolic pathways, possibly impacting CBWD5 activity through phosphorylation or other regulatory mechanisms. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates JNK and p38 MAP kinase pathways, which can result in the activation of transcription factors and proteins, potentially including CBWD5. | ||||||